STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive: Previous study has shown that BCR-ABL1, a hallmark of CML, activates STAT3 via both the Janus Kinase (JAK) and mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK/ERK) pathways (12).